Leonardo Roever Shares a Study on Eligibility Criteria for Endovascular Thrombectomy
Leonardo Roever, CEO of Brazilian Evidence-Based Health Network, shared on LinkedIn:
”Endovascular Thrombectomy for Acute Stroke: Evolving Eligibility Criteria and Adjuvant Therapies
In this review, the authors present recent developments, highlighting how biological targets align with the pathophysiological chronology of primary and secondary injury after an ischemic stroke.
It also discusses why some clinical trials have demonstrated success and others may not, and proposes important considerations for the planning of future trials.
This synthesis aims to inform about the evolving evidence for the treatment of acute ischemic stroke and inspire the planning of clinical trials and next-generation therapies.
See the article.
Follow me for more content on evidence, management, and innovation in healthcare!”
Read the full article here.
Article: Endovascular thrombectomy for acute stroke: evolving eligibility criteria and adjunct therapies
Authors: Martina Glavan, Jia Liu, Gisele Sampaio Silva, Thanh N Nguyen, Jiangbing Zhou, Nenad Sestan et al.
Stay updated on all scientific advances with Hemostasis Today.
-
May 22, 2026, 15:02Robert Brodsky: Can You Stop Thrombosis and Treat CAPS Without Anticoagulation?
-
May 22, 2026, 14:50Eric Topol: New Nature Editorial on the Limits and Promise of AI Scientists
-
May 22, 2026, 14:40Harry Spoelstra: Omicron COVID-19 and Coronary Thrombosis Without Atherosclerosis
-
May 22, 2026, 14:21Clinical Challenges in Thrombosis III – Thrombosis Canada
-
May 22, 2026, 14:03Wolfgang Miesbach: Exploring the Role of Micronutrients in Healthy Longevity
-
May 22, 2026, 13:53Masoabi Sefojane: The Structural Invisibility of Bleeding Disorders in the Global South
-
May 22, 2026, 13:41Ney Carter Borges: New Trial Highlights IVL as Effective Strategy for Calcified Coronary Lesions
-
May 22, 2026, 13:36Ajay Samkaria։ A Compatible Crossmatch Does Not Always Mean Complete Safety
-
May 22, 2026, 13:31Mariam Swidan: Why Hemolysis Severity Matters in G6PD Deficiency